TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Researchers report that 16 blood molecules linked to brain aging and dementia risk rise across the menopause transition. The protein signature was associated with poorer cognitive outcomes and a modestly higher risk of Alzheimer’s dementia in one large cohort, but the findings do not show that menopause causes the disease.
Researchers led by teams at UC Santa Barbara and UC San Francisco have identified blood protein changes linked to the menopause transition that were also associated with later-life cognitive outcomes. In a study published in Nature Medicine, the researchers found increases in 16 molecules implicated in brain aging and dementia risk, while stressing that the results do not show that menopause causes Alzheimer’s disease.
The team used proteomic technologies to examine thousands of proteins in women at premenopausal, perimenopausal and postmenopausal stages who were part of the UCSB Healthy Aging Study. The researchers identified proteins that changed across the transition, including molecules involved in inflammatory and neuronal processes and proteins associated with Alzheimer’s disease. The pattern was more closely related to menopause stage than to participants’ exact ages, the report said.
The researchers checked their findings against data from more than 2,800 women in the UK Biobank. That analysis also linked menopause with molecular signatures associated with accelerated aging across multiple organ systems. To examine links with brain health, the team then analyzed four independent cohorts totaling nearly 12,000 older women.
In those cohorts, higher levels of the identified “risk” proteins were associated with poorer cognitive outcomes. In the largest cohort, the protein signature was associated with a modestly greater risk of Alzheimer’s dementia over the following 16 years. The study authors said the proteins may offer clues to biological changes that begin in midlife, but the clinical meaning of individual changes remains uncertain.
Why Menopause May Mark a Research Window
The findings offer researchers a way to investigate whether biological changes around menopause are related to brain health years later. Menopause is often studied as a reproductive transition, but this work points to blood-based molecular changes across multiple body systems that could help explain connections between midlife and later-life health.
The results could guide future work on identifying people who might benefit from interventions to support healthy aging. The authors’ longer-term goal is to develop a blood test that could help flag dementia risk in midlife, in a role they compare with cholesterol testing for heart disease risk. No such test is established by this study, and the findings do not show that acting on these proteins would prevent dementia.
Senior author Kaitlin Casaletto said midlife may be a period when brain resilience or vulnerability is shaped, and that menopause could be a particularly relevant time for women. That is a research rationale, not a demonstrated treatment window: the study measured associations and does not establish what interventions would help or who should receive them.
Products Worth Considering
Withings BPM Connect Wi-Fi and Bluetooth Blood Pressure Monitor
Fitbit Inspire 3 Health and Fitness Tracker Bundle
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
As an affiliate, we earn on qualifying purchases.
How Researchers Traced the Protein Pattern
The study was led by Madeline Wood Alexander of Sunnybrook Research Institute and Rowan Saloner and Kaitlin Casaletto of UCSF, with collaborators including researchers at UCSB, Stanford University and the University of Toronto. The work combined a midlife study of protein changes with external datasets and cohorts focused on older women’s cognitive and dementia outcomes.
Emily Jacobs, a UCSB professor of psychological and brain sciences, described menopause as a whole-body biological transition and said the study’s findings offer a way to examine its molecular signature in blood. The paper, titled Blood proteomics of menopause map to brain aging and dementia risk, was published in Nature Medicine. The work received support in part from the Ann S. Bowers Women’s Brain Health Initiative, Wellcome Leap, the National Institutes of Health and the Noyce Trust.
“For women, menopause may be this especially powerful time to intervene.”
— Kaitlin Casaletto, study senior author
What the Protein Associations Cannot Show
The study does not establish that menopause triggers dementia, or that the 16 proteins cause cognitive decline. The results are associations, and the report says the clinical significance of individual Alzheimer’s-related protein changes detected in midlife remains unclear. Most women do not develop Alzheimer’s disease, Casaletto noted.
The researchers also say longitudinal research is needed to track the same women over time. The current findings do not determine how hormone changes, proteins, menopause symptoms and brain health unfold together, or whether the observed protein signature can reliably predict an individual’s future risk. The source report does not provide enough detail to assess how the findings might apply to all women or to people outside the studied cohorts.
Longitudinal Menopause Project Begins
The research team is launching the Longitudinal Menopause Project to follow women across the transition and study changes in hormones, proteins, symptoms and brain health over time. The authors say that kind of follow-up will be essential for clarifying how these measures relate to one another and whether the protein patterns can help identify risk or resilience.
The project is recruiting researchers, according to the report. Further studies will be needed before a blood test or a menopause-timed intervention can be evaluated for clinical use. For now, the next step is to establish how the molecular changes develop within individuals and how consistently they relate to later cognitive outcomes.
Key Questions
Does this study show that menopause causes Alzheimer’s disease?
No. The researchers found associations between menopause-stage protein patterns and later-life cognitive outcomes, but the study does not establish that menopause causes Alzheimer’s or that the proteins cause dementia.
What did the researchers find in the blood?
They identified increases in 16 molecules implicated in brain aging and dementia risk, along with a wider set of proteins that changed across the menopause transition. The proteins included molecules involved in inflammatory and neuronal processes.
How many people were included in the analyses?
The researchers examined a UK Biobank dataset with more than 2,800 women and four older-women cohorts totaling nearly 12,000 participants, alongside the UCSB Healthy Aging Study. These are separate parts of the research, not one combined cohort.
Is there a blood test for dementia risk based on these findings?
No validated clinical test is reported. The team hopes the findings may contribute to developing a blood test in the future, but additional research is needed to determine whether the protein signature can predict risk reliably and guide care.
What research is planned next?
The team is launching the Longitudinal Menopause Project to follow women over time and study how hormones, proteins, symptoms and brain health change across menopause.
Source: news-medical.net
